Miguel D Regueiro1, Julia B Greer, David G Binion, Wolfgang H Schraut, Alka Goyal, David J Keljo, Raymond K Cross, Emmanuelle D Williams, Hans H Herfarth, Corey A Siegel, Ioannis Oikonomou, Myron H Brand, Douglas J Hartman, Mitchell E Tublin, Peter L Davis, Leonard Baidoo, Eva Szigethy, Andrew R Watson. 1. 1Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, University of Pittsburgh School of Medicine Center, Pittsburgh, Pennsylvania; 2Department of Surgery, Division of Surgical Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; 3Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; 4Department of Medicine, Division of Gastroenterology and Hepatology, University of Maryland, Baltimore, Baltimore, Maryland; 5Department of Medicine, Division of Gastroenterology and Hepatology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania; 6Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina; 7Department of Medicine, Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; 8Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut; 9Gastroenterology Consultants of Connecticut, New Haven, Connecticut; 10Department of Pathology, Division of Anatomic Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; 11Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Departments of 12Psychiatry, 13Pediatrics, and 14Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and 15Department of Surgery, Division of Colon and Rectal Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND: Managing patients with inflammatory bowel disease requires multidisciplinary coordination. Technological advances have enhanced access to care for patients and improved physician interactions. The primary aim of our project was to convene diverse institutions and specialties through a multisite virtual conferencing platform to discuss complex patient management. METHODS: The case conference is designed to include multiple institutions to exchange ideas, review evidence-based data, and provide input on the management of patients with Crohn's disease and ulcerative colitis. Technology is supplied and coordinated by an information technology specialist and Chorus Call, Inc., an international teleconferencing service provider. The Inflammatory Bowel Disease Live Interinstitutional Interdisciplinary Videoconference Education (IBD LIVE) initiative is accredited by the University of Pittsburgh Medical Center (UPMC) Center for Continuing Education in the Health Sciences for 1 AMA PRA Category 1 Credit per weekly session. RESULTS: IBD LIVE began in 2009 comprising only adult gastroenterology and pediatric gastroenterology from UPMC Presbyterian and Children's Hospitals. Participation steadily increased from 5 sites in 2010 to 11 sites in 2014. Maximum attendance for a single conference was 73 participants with a median of 48. The Continuing Medical Education scores (1 = worst to 5 = best) have a high median overall score (4.6, range 3.2-5.0) with positive responses with regard to the degree to which the conference changed practice. CONCLUSIONS: IBD LIVE has been successful and continues to grow. Implementation of the Crohn's and Colitis Foundation of America Virtual Preceptor Program using the IBD LIVE platform will provide expanded national physician access to this professional education activity.
BACKGROUND: Managing patients with inflammatory bowel disease requires multidisciplinary coordination. Technological advances have enhanced access to care for patients and improved physician interactions. The primary aim of our project was to convene diverse institutions and specialties through a multisite virtual conferencing platform to discuss complex patient management. METHODS: The case conference is designed to include multiple institutions to exchange ideas, review evidence-based data, and provide input on the management of patients with Crohn's disease and ulcerative colitis. Technology is supplied and coordinated by an information technology specialist and Chorus Call, Inc., an international teleconferencing service provider. The Inflammatory Bowel Disease Live Interinstitutional Interdisciplinary Videoconference Education (IBD LIVE) initiative is accredited by the University of Pittsburgh Medical Center (UPMC) Center for Continuing Education in the Health Sciences for 1 AMA PRA Category 1 Credit per weekly session. RESULTS: IBD LIVE began in 2009 comprising only adult gastroenterology and pediatric gastroenterology from UPMC Presbyterian and Children's Hospitals. Participation steadily increased from 5 sites in 2010 to 11 sites in 2014. Maximum attendance for a single conference was 73 participants with a median of 48. The Continuing Medical Education scores (1 = worst to 5 = best) have a high median overall score (4.6, range 3.2-5.0) with positive responses with regard to the degree to which the conference changed practice. CONCLUSIONS: IBD LIVE has been successful and continues to grow. Implementation of the Crohn's and Colitis Foundation of America Virtual Preceptor Program using the IBD LIVE platform will provide expanded national physician access to this professional education activity.
Authors: Kathleen Boynton; Ann Flynn; Terry Box; Anthony Dalpiaz; Leah Willis; Tyson Kay; John F Valentine Journal: Inflamm Bowel Dis Date: 2015-06 Impact factor: 5.325
Authors: Christine Yu; Stephanie Tovar; Jiaxiao Shi; Ariadna Padilla; Dana Pounds; Welmoed K van Deen; Christopher V Almario; Bechien U Wu Journal: Clin Transl Gastroenterol Date: 2022-09-01 Impact factor: 4.396